SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J. Yue, M. Yang, S. Yi, B. Dong, W. Li, Z. Yang, J. Lu, R. Zhang, J. Yong, Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study, Osteoarthritis and Cartilage, 2012,

    CrossRef

  2. 2
    R. C. Gupta, T. D. Canerdy, J. Lindley, M. Konemann, J. Minniear, B. A. Carroll, C. Hendrick, J. T. Goad, K. Rohde, R. Doss, M. Bagchi, D. Bagchi, Comparative therapeutic efficacy and safety of type-II collagen (uc-II), glucosamine and chondroitin in arthritic dogs: pain evaluation by ground force plate, Journal of Animal Physiology and Animal Nutrition, 2012, 96, 3
  3. 3
    Alexander G. Schauss, Jerome Stenehjem, Joosang Park, John R. Endres, Amy Clewell, Effect of the Novel Low Molecular Weight Hydrolyzed Chicken Sternal Cartilage Extract, BioCell Collagen, on Improving Osteoarthritis-Related Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Agricultural and Food Chemistry, 2012, 60, 16, 4096

    CrossRef

  4. 4
    Cyrus Cooper, Jean-Yves Reginster, Roland Chapurlat, Claus Christiansen, Harry Genant, Nicholas Bellamy, William Bensen, Federico Navarro, Janusz Badurski, Evgeny Nasonov, Xavier Chevalier, Philip N. Sambrook, Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial, Current Medical Research and Opinion, 2012, 28, 2, 231

    CrossRef

  5. 5
    Yves Henrotin, Ali Mobasheri, Marc Marty, Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?, Arthritis Research & Therapy, 2012, 14, 1, 201

    CrossRef

  6. 6
    R.L. Manno, C.O. Bingham, S. Paternotte, L. Gossec, H. Halhol, G. Giacovelli, L. Rovati, S.A. Mazzuca, D.O. Clegg, H. Shi, E. Tajana Messi, A. Lanzarotti, M. Dougados, OARSI–OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials, Osteoarthritis and Cartilage, 2012, 20, 2, 93

    CrossRef

  7. 7
    Jean-Yves Reginster, Audrey Neuprez, Marie-Paule Lecart, Nathalie Sarlet, Olivier Bruyere, Role of glucosamine in the treatment for osteoarthritis, Rheumatology International, 2012,

    CrossRef

  8. 8
    Andrew L. Sherman, German Ojeda-Correal, Jose Mena, Use of Glucosamine and Chondroitin in Persons With Osteoarthritis, PM&R, 2012, 4, 5, S110

    CrossRef

  9. 9
    Manon C Zweers, Tineke N de Boer, Joël van Roon, Johannes WJ Bijlsma, Floris PJG Lafeber, Simon C Mastbergen, Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis, Arthritis Research & Therapy, 2011, 13, 5, 239

    CrossRef

  10. 10
    R. J. Maughan, P. L. Greenhaff, P. Hespel, Dietary supplements for athletes: Emerging trends and recurring themes, Journal of Sports Sciences, 2011, 29, sup1, S57

    CrossRef

  11. 11
    Jörg Jerosch, Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids, International Journal of Rheumatology, 2011, 2011, 1

    CrossRef

  12. 12
    Karla L. Miller, Daniel O. Clegg, Glucosamine and Chondroitin Sulfate, Rheumatic Disease Clinics of North America, 2011, 37, 1, 103

    CrossRef

  13. 13
    Susan J. Bartlett, Shari M. Ling, Nancy E. Mayo, Susan C. Scott, Clifton O. Bingham, Identifying common trajectories of joint space narrowing over two years in knee osteoarthritis, Arthritis Care & Research, 2011, 63, 12
  14. 14
    Jae-Seon So, Min-Kyung Song, Ho-Keun Kwon, Choong-Gu Lee, Chang-Suk Chae, Anupama Sahoo, Arijita Jash, Sung Haeng Lee, Zee Yong Park, Sin-Hyeog Im, Lactobacillus casei enhances type II collagen/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritis, Life Sciences, 2011, 88, 7-8, 358

    CrossRef

  15. 15
    J.M. Jordan, M.F. Sowers, S.P. Messier, J. Bradley, G. Arangio, J.N. Katz, E. Losina, L. Rovati, N. Bachtell, C. Cooper, T. Spector, W. Zhang, J. Gardiner, M. Wahba, Methodologic issues in clinical trials for prevention or risk reduction in osteoarthritis, Osteoarthritis and Cartilage, 2011, 19, 5, 500

    CrossRef

  16. 16
    Akhtar A. Ali, Sherry M. Lewis, Heidi L. Badgley, William T. Allaben, Julian E.A. Leakey, Oral glucosamine increases expression of transforming growth factor β1 (TGFβ1) and connective tissue growth factor (CTGF) mRNA in rat cartilage and kidney: Implications for human efficacy and toxicity, Archives of Biochemistry and Biophysics, 2011, 510, 1, 11

    CrossRef

  17. 17
    Umberto Tarantino, Amedeo Ferlosio, Gaetano Arcuri, Luigi Giusto Spagnoli, Augusto Orlandi, Transglutaminase 2 as a biomarker of osteoarthritis: an update, Amino Acids, 2011,

    CrossRef

  18. You have free access to this content18
    Evan S. VISTA, Chak S. LAU, What about supplements for osteoarthritis? A critical and evidenced-based review, International Journal of Rheumatic Diseases, 2011, 14, 2
  19. 19
    DONNA M. URQUHART, JEPHTAH F. L. TOBING, FAHAD S. HANNA, PATRICIA BERRY, ANITA E. WLUKA, CHANGHAI DING, FLAVIA M. CICUTTINI, What Is the Effect of Physical Activity on the Knee Joint? A Systematic Review, Medicine & Science in Sports & Exercise, 2011, 43, 3, 432

    CrossRef

  20. 20
    Stanley Naguwa, Arthritis, 2011,

    CrossRef

  21. 21
    Maxime Dougados, Marc C. Hochberg, Rheumatology, 2011,

    CrossRef

  22. 22
    D.R. McCulloch, J.D. Wylie, J.-M. Longpre, R. Leduc, S.S. Apte, 10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furin, Osteoarthritis and Cartilage, 2010, 18, 3, 455

    CrossRef

  23. 23
    Erica Lovett, Neelima Ganta, Advising Patients About Herbs and Nutraceuticals: Tips for Primary Care Providers, Primary Care: Clinics in Office Practice, 2010, 37, 1, 13

    CrossRef

  24. 24
    Charles J. Malemud, Anticytokine Therapy for Osteoarthritis, Drugs & Aging, 2010, 27, 2, 95

    CrossRef

  25. 25
    Gunnar Flugsrud, Lars Nordsletten, Finn Reinholt, May Risberg, Karin Rydevik, Till Uhlig, Artrose, Tidsskrift for Den norske legeforening, 2010, 130, 21, 2136

    CrossRef

  26. 26
    Jorge A Roman-Blas, Santos Castañeda, Raquel Largo, Gabriel Herrero-Beaumont, Glucosamine sulfate for knee osteoarthritis: science and evidence-based use, Therapy, 2010, 7, 6, 591

    CrossRef

  27. 27
    Hilde Berge, Svein Gjelstad, Kari Furu, Jørund Straand, Glukosaminbruk reduserer ikke behovet for analgetika, Tidsskrift for Den norske legeforening, 2010, 130, 15, 1463

    CrossRef

  28. 28
    Juhua Zhou, Prakash Nagarkatti, Yin Zhong, Mitzi Nagarkatti, Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosis, Journal of Neuroimmunology, 2010, 223, 1-2, 55

    CrossRef

  29. 29
    Déborah Gensburger, Jean-Paul Roux, Monique Arlot, Elisabeth Sornay-Rendu, Philippe Ravaud, Roland Chapurlat, Influence of blinding sequence of radiographs on the reproducibility and sensitivity to change of joint space width measurement in knee osteoarthritis, Arthritis Care & Research, 2010, 62, 12
  30. 30
    W. Zhang, G. Nuki, R.W. Moskowitz, S. Abramson, R.D. Altman, N.K. Arden, S. Bierma-Zeinstra, K.D. Brandt, P. Croft, M. Doherty, M. Dougados, M. Hochberg, D.J. Hunter, K. Kwoh, L.S. Lohmander, P. Tugwell, OARSI recommendations for the management of hip and knee osteoarthritis, Osteoarthritis and Cartilage, 2010, 18, 4, 476

    CrossRef

  31. 31
    M.C. Hochberg, Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration, Osteoarthritis and Cartilage, 2010, 18, S28

    CrossRef

  32. 32
    Micronutrients in Health and Disease, 2010,

    CrossRef

  33. 33
    Mathilde Michon, Jérémie Sellam, Francis Berenbaum, Targeted Treatment of the Rheumatic Diseases, 2010,

    CrossRef

  34. 34
    Jonathan D. Morris, Kelly M. Smith, Chondroitin Sulfate in Osteoarthritis Therapy, Orthopedics, 2009, 32, 4, 268

    CrossRef

  35. 35
    J. Katta, Z. Jin, E. Ingham, J. Fisher, Chondroitin sulphate: an effective joint lubricant?, Osteoarthritis and Cartilage, 2009, 17, 8, 1001

    CrossRef

  36. 36
    J. E Silbert, Dietary glucosamine under question, Glycobiology, 2009, 19, 6, 564

    CrossRef

  37. 37
    Changhai Ding, Flavia Cicuttini, Graeme Jones, Do NSAIDs Affect Longitudinal Changes in Knee Cartilage Volume and Knee Cartilage Defects in Older Adults?, The American Journal of Medicine, 2009, 122, 9, 836

    CrossRef

  38. 38
    David Hemenway, How to find nothing, Journal of Public Health Policy, 2009, 30, 3, 260

    CrossRef

  39. 39
    K.D. Rainsford, Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: a critique, Journal of Pharmacy and Pharmacology, 2009, 61, 10
  40. 40
    Rebecca F. Cady, Legal Issues Related to Complementary and Alternative Medicine, JONA's Healthcare, Law, Ethics, and Regulation, 2009, 11, 2, 46

    CrossRef

  41. 41
    Jack Challem, Medical Journal Watch: Context and Applications, Alternative and Complementary Therapies, 2009, 15, 3, 156

    CrossRef

  42. 42
    Kenneth D. Brandt, Steven A. Mazzuca, Barry P. Katz, Methodology and statistical analysis in the Glucosamine/Chondroitin Arthritis Intervention Trial: Comment on the article by Sawitzke et al, Arthritis & Rheumatism, 2009, 60, 11
  43. 43
    S. Panicker, J. Borgia, C. Fhied, K. Mikecz, T.R. Oegema, Oral glucosamine modulates the response of the liver and lymphocytes of the mesenteric lymph nodes in a papain-induced model of joint damage and repair, Osteoarthritis and Cartilage, 2009, 17, 8, 1014

    CrossRef

  44. 44
    Nicola Volpi, Quality of different chondroitin sulfate preparations in relation to their therapeutic activity, Journal of Pharmacy and Pharmacology, 2009, 61, 10
  45. 45
    Marie-Pierre Hellio Le Graverand, Steve Mazzuca, Jeff Duryea, Alan Brett, Radiographic Grading and Measurement of Joint Space Width in Osteoarthritis, Rheumatic Disease Clinics of North America, 2009, 35, 3, 485

    CrossRef

  46. 46
    Marie-Pierre Hellio Le Graverand, Steve Mazzuca, Jeff Duryea, Alan Brett, Radiographic-Based Grading Methods and Radiographic Measurement of Joint Space Width in Osteoarthritis, Radiologic Clinics of North America, 2009, 47, 4, 567

    CrossRef

  47. 47
    Déborah Gensburger, Monique Arlot, Elisabeth Sornay-Rendu, Jean-paul Roux, Pierre Delmas, Radiologic assessment of age-related knee joint space changes in women: A 4-year longitudinal study, Arthritis Care & Research, 2009, 61, 3
  48. 48
    Richard Wigley, The glucosamine debate: is it better than placebo?, Inflammopharmacology, 2009, 17, 3, 191

    CrossRef

  49. 49
    J.L. Huebner, K.A. Johnson, V.B. Kraus, R.A. Terkeltaub, Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OA, Osteoarthritis and Cartilage, 2009, 17, 8, 1056

    CrossRef

  50. 50
    Meghan Bodenberg, Holly Byrnes, Handbook of Nutraceuticals Volume I, 2009,

    CrossRef